| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Chess Robert serves as a Director at NKTR and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 55 sells. Those positions are worth an estimated $21.4M at current prices.
Historically, Chess Robert's trades have earned a strong insider score of 84/100 across 22 rated trades. Over a 12-month horizon, 95.5% of those trades were profitable, with an average 12-month return of +58.1%.
The biggest single holding is NKTR (~$19.3M) as Director. The recent filings there lean toward selling, a net 256,800 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2018 | NKTR Nektar Therapeutics | Director | Sale+OE | 25,000 | $92.14 | $2,303,600.00 | -4.4% | |
| Sep 21, 2017 | NKTR Nektar Therapeutics | Director | Sell | 6,400 | $21.72 | $139,008.00 | -2.3% | |
| May 15, 2017 | NKTR Nektar Therapeutics | Director | Sale+OE | 5,000 | $19.79 | $98,950.00 | -1.8% | |
| Apr 17, 2017 | NKTR Nektar Therapeutics | Director | Sale+OE | 5,000 | $18.72 | $93,600.00 | -1.8% | |
| Mar 14, 2017 | NKTR Nektar Therapeutics | Director | Sale+OE | 5,000 | $15.41 | $77,050.00 | -1.8% | |
| Sep 15, 2016 | NKTR Nektar Therapeutics | Director | Sale+OE | 12,000 | $19.21 | $230,520.00 | -4.6% | |
| Aug 1, 2016 | NKTR Nektar Therapeutics | Director | Sale+OE | 5,000 | $17.26 | $86,300.00 | -1.9% | |
| Jul 1, 2016 | NKTR Nektar Therapeutics | Director | Sale+OE | 5,000 | $14.10 | $70,500.00 | -1.9% | |
| Jun 1, 2016 | NKTR Nektar Therapeutics | Director | Sale+OE | 5,000 | $15.50 | $77,500.00 | -1.9% | |
| Jun 19, 2015 | NKTR Nektar Therapeutics | Director | Sale+OE | 15,000 | $11.81 | $177,150.00 | -5.4% |